コンテンツへスキップ
Merck
  • A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery.

A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery.

Combinatorial chemistry & high throughput screening (2015-04-02)
Lance Heinle, Vincent Peterkin, Sonia M de Morais, Gary J Jenkins, Ilaria Badagnani
要旨

A high throughput, semi-automated clearance screening assay in hepatocytes was developed allowing a scientist to generate data for 96 compounds in one week. The 384-well format assay utilizes a Thermo Multidrop Combi and an optimized LC-MS/MS method. The previously reported LCMS/ MS method reduced the analytical run time by 3-fold, down to 1.2 min injection-to-injection. The Multidrop was able to deliver hepatocytes to 384-well plates with minimal viability loss. Comparison of results from the new 384-well and historical 24-well assays yielded a correlation of 0.95. In addition, results obtained for 25 marketed drugs with various metabolism pathways had a correlation of 0.75 when compared with literature values. Precision was maintained in the new format as 8 compounds tested in ≥39 independent experiments had coefficients of variation ≤21%. The ability to predict in vivo clearances using the new stability assay format was also investigated using 22 marketed drugs and 26 AbbVie compounds. Correction of intrinsic clearance values with binding to hepatocytes (in vitro data) and plasma (in vivo data) resulted in a higher in vitro to in vivo correlation when comparing 22 marketed compounds in human (0.80 vs 0.35) and 26 AbbVie Discovery compounds in rat (0.56 vs 0.17), demonstrating the importance of correcting for binding in clearance studies. This newly developed high throughput, semi-automated clearance assay allows for rapid screening of Discovery compounds to enable Structure Activity Relationship (SAR) analysis based on high quality hepatocyte stability data in sufficient quantity and quality to drive the next round of compound synthesis.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, for molecular biology
Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
エタノール, JIS special grade, ≥99.5%
Sigma-Aldrich
ジメチルスルホキシド, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
エタノール, SAJ first grade, ≥99.5%
Sigma-Aldrich
ジメチルスルホキシド, PCR Reagent
Sigma-Aldrich
エチルアルコール(純粋), 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
ウンベリフェロン, 99%
Sigma-Aldrich
ジメチルスルホキシド, anhydrous, ≥99.9%
Supelco
エタノール標準品10% (v/v), 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
エタノール, ≥99.5%, suitable for HPLC
Sigma-Aldrich
エタノール, JIS special grade, 94.8-95.8%
Sigma-Aldrich
エタノール, ≥99.5%
Sigma-Aldrich
フェノールレッド, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
フェノールレッド, ACS reagent
Sigma-Aldrich
ウンベリフェロン, suitable for fluorescence indicator, ≥98.0% (HPLC)
Sigma-Aldrich
エタノール, ≥99.5%, suitable for absorption spectrum analysis
Sigma-Aldrich
Ethanol Fixative 80% v/v, suitable for fixing solution (blood films)
Sigma-Aldrich
ジメチルスルホキシド, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
エタノール, 94.8-95.8%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5%
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
ジメチルスルホキシド, JIS special grade, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, Vetec, reagent grade, 99%
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC
Sigma-Aldrich
エタノール, ≥99.5%, SAJ super special grade
Sigma-Aldrich
ジメチルスルホキシド, SAJ first grade, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.0%, suitable for absorption spectrum analysis